Amgen (AMGN)
438.94
0.00 (0.00%)
Upcoming Events
Latest Headlines
Amgen (AMGN) PT Raised to $400 at Barclays
October 21, 2026 3:15 AM - StreetInsider
AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026
October 20, 2026 4:15 PM - PR NewsWire
Amgen's tezepelumab hits Phase 3 targets in esophageal disorder trial
October 20, 2026 9:04 AM - StreetInsider
TEZSPIRE® DELIVERED HISTOLOGIC REMISSION AND SYMPTOM IMPROVEMENT IN EOSINOPHILIC ESOPHAGITIS
October 20, 2026 9:01 AM - PR NewsWire
Amgen (AMGN) PT Lowered to $415 at BMO Capital
October 12, 2026 9:53 AM - StreetInsider
Amgen (AMGN) PT Lowered to $378 at Guggenheim
October 12, 2026 9:38 AM - StreetInsider
Amgen (AMGN) PT Lowered to $430 at Wells Fargo
October 12, 2026 6:31 AM - StreetInsider
Amgen (AMGN) PT Raised to $470 at UBS
October 9, 2026 9:06 AM - StreetInsider
Amgen (AMGN) PT Raised to $430 at RBC Capital
October 8, 2026 8:26 AM - StreetInsider
Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
October 8, 2026 7:11 AM - StreetInsider
Amgen (AMGN) PT Lowered to $359 at Morgan Stanley
October 7, 2026 7:58 AM - StreetInsider
Amgen (AMGN) PT Raised to $380 at Truist Securities
October 7, 2026 7:13 AM - StreetInsider
Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
October 5, 2026 7:43 AM - StreetInsider
Amgen (AMGN) PT Raised to $500 at Scotiabank
September 29, 2026 7:23 AM - StreetInsider
Canaccord Reiterates Hold Rating on Amgen (AMGN)
September 23, 2026 6:38 AM - StreetInsider
Amgen (AMGN) PT Raised to $410 at Jefferies
September 23, 2026 5:27 AM - StreetInsider
Oppenheimer Reiterates Outperform Rating on Amgen (AMGN)
September 23, 2026 5:24 AM - StreetInsider
Amgen's dazodalibep meets primary endpoint in Sjögren's Phase 3 trial
September 22, 2026 9:02 AM - StreetInsider
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE
September 22, 2026 9:02 AM - PR NewsWire
Roche obesity drug shows 15.5% weight loss in diabetes trial
September 22, 2026 7:26 AM - StreetInsider
Amgen (AMGN) PT Lowered to $430 at UBS
September 17, 2026 8:28 AM - StreetInsider
FDA cuts monitoring time for Amgen's Imdelltra initial doses
September 14, 2026 9:01 AM - StreetInsider
FDA APPROVES REDUCED MONITORING TIME FOR FIRST TWO DOSES OF IMDELLTRA®
September 14, 2026 9:00 AM - PR NewsWire
HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
September 10, 2026 6:38 AM - StreetInsider
HSBC Downgrades Amgen (AMGN) to Hold
September 10, 2026 3:21 AM - StreetInsider
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
September 9, 2026 4:01 PM - PR NewsWire
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
September 8, 2026 7:22 AM - StreetInsider
Amgen (AMGN) call put ratio 1 call 1 put
September 8, 2026 5:28 AM - StreetInsider
BMO Capital Downgrades Amgen (AMGN) to Market Perform
September 8, 2026 4:36 AM - StreetInsider
Amgen (AMGN) PT Raised to $435 at Wells Fargo
September 4, 2026 5:27 AM - StreetInsider
Amgen (AMGN) call put ratio 1 call to 1.1 puts
August 31, 2026 5:47 AM - StreetInsider
Amgen's Tezspire meets all endpoints in phase 3 esophagitis trial
August 27, 2026 2:00 AM - StreetInsider
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
August 27, 2026 2:00 AM - PR NewsWire
FTC files amicus brief challenging Amgen's Enbrel patent acquisition
August 21, 2026 11:58 AM - StreetInsider
Amgen (AMGN) PT Raised to $457 at Piper Sandler
August 20, 2026 7:22 AM - StreetInsider
Amgen (AMGN) PT Raised to $362 at Morgan Stanley
August 19, 2026 9:07 AM - StreetInsider
Amgen (AMGN) PT Raised to $460 at Argus
August 19, 2026 7:24 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
August 18, 2026 8:52 AM - StreetInsider
Amgen (AMGN) PT Raised to $352 at Mizuho
August 18, 2026 6:36 AM - StreetInsider
Amgen (AMGN) PT Raised to $380 at Barclays
August 14, 2026 4:20 AM - StreetInsider
Form 4 AMGEN INC For: Aug 11 Filed by: Khosla Rachna
August 13, 2026 7:06 PM - SEC Filing
Form 144 AMGEN INC Filed by: Khosla Rachna
August 13, 2026 11:14 AM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: Busch Matthew C.
August 12, 2026 8:05 PM - SEC Filing
Form 144 AMGEN INC Filed by: Khosla Rachna
August 11, 2026 3:41 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: ISHRAK OMAR
August 10, 2026 8:24 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: HOLLEY CHARLES M
August 10, 2026 8:22 PM - SEC Filing
Form 4 AMGEN INC For: Aug 07 Filed by: Drake Michael V
August 10, 2026 8:20 PM - SEC Filing
Amgen (AMGN) PT Raised to $388 at Guggenheim
August 10, 2026 7:28 AM - StreetInsider
Form 4 AMGEN INC For: Aug 06 Filed by: Miller Derek
August 7, 2026 6:47 PM - SEC Filing
Form 4 AMGEN INC For: Aug 06 Filed by: Grygiel Nancy A.
August 7, 2026 6:46 PM - SEC Filing
Morgan Stanley tracks US drug market prescriptions for week ending July 31
August 7, 2026 12:04 PM - StreetInsider
Form 144 AMGEN INC Filed by: Miller Derek
August 6, 2026 5:10 PM - SEC Filing
Form 144/A AMGEN INC Filed by: Grygiel Nancy A.
August 6, 2026 3:17 PM - SEC Filing
Form 144 AMGEN INC Filed by: Grygiel Nancy A.
August 6, 2026 2:13 PM - SEC Filing
Amgen (AMGN) PT Raised to $345 at Bernstein SocGen Group
August 6, 2026 9:24 AM - StreetInsider
Amgen (AMGN) PT Raised to $440 at UBS
August 5, 2026 8:54 AM - StreetInsider
Amgen (AMGN) PT Raised to $452 at TD Cowen
August 5, 2026 8:11 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at Wells Fargo
August 5, 2026 7:56 AM - StreetInsider
Amgen (AMGN) PT Raised to $400 at RBC Capital After an 'Impressive Q'
August 5, 2026 7:44 AM - StreetInsider
Amgen (AMGN) PT Raised to $450 at BMO Capital
August 5, 2026 7:11 AM - StreetInsider
Form 10-Q AMGEN INC For: Jun 30
August 5, 2026 6:02 AM - SEC Filing
Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
August 4, 2026 4:04 PM - StreetInsider
Form 8-K AMGEN INC For: Aug 04
August 4, 2026 4:04 PM - SEC Filing
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
August 4, 2026 4:01 PM - PR NewsWire
Amgen (AMGN) call put ratio 1.1 calls to 1 put into quarter results
August 4, 2026 10:46 AM - StreetInsider
Amgen (AMGN) call put ratio 1 call to 2 puts into quarter results
August 3, 2026 10:32 AM - StreetInsider
Amgen (AMGN) call put ratio 2.4 calls to 1 put into quarter results
August 3, 2026 6:05 AM - StreetInsider
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Amgen reports data breach involving patient and proprietary data
July 31, 2026 4:07 PM - StreetInsider
Form 8-K AMGEN INC For: Jul 29
July 31, 2026 4:04 PM - SEC Filing
Amgen (AMGN) call put ratio 3.8 calls to 1 put with a focus on July 31 weekly calls into quarter results
July 31, 2026 11:03 AM - StreetInsider
Amgen (AMGN) Declares $2.52 Quarterly Dividend; 2.6% Yield
July 30, 2026 4:02 PM - StreetInsider
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND
July 30, 2026 4:01 PM - PR NewsWire
Amgen (AMGN) PT Raised to $360 at Barclays
July 29, 2026 5:19 AM - StreetInsider
AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
July 28, 2026 4:45 PM - PR NewsWire
Full Article List
